Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wilfried Den Tandt
Chitinase in Humans Is a Marker for Gaucher Disease. Potential for Monitoring Therapy. 850
Pediatric Research
Child Health
Pediatrics
Perinatology
Related publications
Arimoclomol as a Potential Therapy for Neuronopathic Gaucher Disease
3. Development of Pharmacological Chaperone Therapy for Neuronopathic Gaucher Disease
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Cost-Effectiveness of Enzyme Replacement Therapy for Type 1 Gaucher Disease
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Glucosylsphingosine Is a Reliable Response Biomarker in Gaucher Disease
American Journal of Hematology
Hematology
PP044 Adherence to Enzyme Replacement Therapy in Gaucher Disease
International Journal of Technology Assessment in Health Care
Health Policy
Psy97 - Cost-Effectiveness Analysis of Enzyme Replacement Therapy for Type 1 Gaucher Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Hepatocyte Growth Factor in Saliva Is a Potential Marker of Symptomatic Periodontal Disease
Journal of oral science
Medicine
Dentistry
Chitinase Inhibitor Allosamidin Is a Signal Molecule for Chitinase Production in Its Producing Streptomyces
Journal of Antibiotics
Drug Discovery
Pharmacology
Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients
Cancer Research
Cancer Research
Oncology